Altasciences CEO Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
LAVAL, QC, Canada (August 15, 2016) — Altasciences, one of the largest early phase clinical CROs in North America, is pleased to announce that Chris Perkin, CEO, has been named one of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine for the second time.
Chris was nominated by his peers, colleagues and employees for being the ideal leader. “He never focuses on problems, only solutions. He delivers on his promises and is able to transform a mass of information into concrete projects. The great thing about Chris is that he is open to all ideas and is always looking to innovate,” said Cathy Konidas, Vice President, Global Business Development, who has worked with Chris for 15 years.
Every year, PharmaVOICE receives thousands of nominations from readers for the most influential corporate leaders in their field. Submissions detail how an individual has inspired them, motivated them, and positively impacted them or their company. Candidates are selected based on their ability to inspire peers through their actions, as well as exhibiting strong leadership qualities, fearless and unique approaches to problem solving, and innovation.
“Thank you to all those who took the time to nominate me; I am touched,” said Chris Perkin. When asked how he would like to be remembered for his work in the industry, Chris replied: “As someone who never compromised on honesty and integrity, and was able to encourage and motivate others to achieve more than they expected.”
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences’ full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
For More Information
Director, Communications and Marketing
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.